GenSight Biologics S.A.
GSGTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,001 | -$26,220 | -$27,625 | -$28,617 |
| Dep. & Amort. | $1,059 | $2,179 | $1,061 | $928 |
| Deferred Tax | $0 | $0 | $0 | $17 |
| Stock-Based Comp. | $784 | $587 | -$3,364 | $4,834 |
| Change in WC | $873 | $2,454 | -$3,916 | $4,841 |
| Other Non-Cash | -$1,652 | -$3,663 | $91 | $858 |
| Operating Cash Flow | -$12,937 | -$24,663 | -$33,753 | -$17,139 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$10 | -$252 | -$32 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $424 | $16 |
| Other Inv. Act. | $18 | $219 | $0 | $0 |
| Investing Cash Flow | $17 | $209 | $172 | -$16 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,153 | $13,101 | $2,978 | -$3,653 |
| Stock Issued | $16,742 | $4,017 | $38 | $439 |
| Stock Repurch. | -$27 | -$99 | -$193 | -$305 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,020 | -$1,160 | -$2,728 | $27,258 |
| Financing Cash Flow | $13,542 | $15,859 | $95 | $23,739 |
| Forex Effect | -$293 | $119 | -$193 | -$238 |
| Net Chg. in Cash | $330 | -$8,476 | -$33,679 | $6,345 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,134 | $10,610 | $44,288 | $37,943 |
| End Cash | $2,464 | $2,134 | $10,609 | $44,288 |
| Free Cash Flow | -$12,938 | -$24,673 | -$34,005 | -$17,171 |